This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Clinicopathological features and prognostic value of SOX11 in childhood acute lymphoblastic leukemia
Scientific Reports Open Access 06 February 2020
-
Circular RNA CEP128 acts as a sponge of miR-145-5p in promoting the bladder cancer progression via regulating SOX11
Molecular Medicine Open Access 31 July 2018
-
Role of Bruton’s tyrosine kinase in B cells and malignancies
Molecular Cancer Open Access 19 February 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn. International Agency for Research on Cancer IARC: Lyon, 2008.
Jares P, Colomer D, Campo E . Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 2007; 7: 750–762.
Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 2005; 106: 4315–4321.
Mozos A, Royo C, Hartmann E, de JD, Baro C, Valera A et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica 2009; 94: 1555–1562.
Xu W, Li JY . SOX11 expression in mantle cell lymphoma. Leuk Lymphoma 2010; 51: 1962–1967.
Dreyling M, Kluin-Nelemans HC, Bea S, Klapper W, Vogt N, fau-Larue MH et al. Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th Annual Conference of the European Mantle Cell Lymphoma Network. Leuk Lymphoma 2013; 54: 699–707.
Bhattaram P, Penzo-Mendez A, Sock E, Colmenares C, Kaneko KJ, Vassilev A et al. Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitors. Nat Commun 2010; 1: 9.
Lefebvre V, Dumitriu B, Penzo-Mendez A, Han Y, Pallavi B . Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int J Biochem Cell Biol 2007; 39: 2195–2214.
Ek S, Dictor M, Jerkeman M, Jirstrom K, Borrebaeck CA . Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood 2008; 111: 800–805.
Wang X, Asplund AC, Porwit A, Flygare J, Smith CI, Christensson B et al. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol 2008; 143: 248–252.
Fernandez V, Salamero O, Espinet B, Sole F, Royo C, Navarro A et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res 2010; 70: 1408–1418.
Nygren L, Baumgartner WS, Klimkowska M, Christensson B, Kimby E, Sander B . Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood 2012; 119: 4215–4223.
Ondrejka SL, Lai R, Smith SD, Hsi ED . Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis. Haematologica 2011; 96: 1121–1127.
Swerdlow SH, Williams ME . From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum Pathol 2002; 33: 7–20.
Bacher U, Kern W, Haferlach C, Alpermann T, Haferlach T, Schnittger S . Cyclin D1 (CCND1) mRNA expression assessed by real-time PCR is increased in patients with mantle cell lymphoma and contributes to diagnosis in B-cell lymphoma cases. Blood 2013; 120: 1595a.
Acknowledgements
We thank all clinicians for sending samples to our laboratory for diagnostic purposes and for providing clinical information and follow-up data. In addition, we thank all the co-workers at the MLL Munich Leukemia Laboratory for approaching together many aspects in the field of leukemia diagnostics and research. Especially, the technical assistance of Antje Stiel and Jessica Brust, who contributed to SOX11 qRT-PCR and IGHV mutational analyses, is greatly appreciated. In addition, we are grateful for the data management support performed by Tamara Alpermann.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
WK, CH, TH and SS have equity ownership of MLL Munich Leukemia Laboratory GmbH. MM is employed by MLL Munich Leukemia Laboratory GmbH.
Rights and permissions
About this article
Cite this article
Meggendorfer, M., Kern, W., Haferlach, C. et al. SOX11 overexpression is a specific marker for mantle cell lymphoma and correlates with t(11;14) translocation, CCND1 expression and an adverse prognosis. Leukemia 27, 2388–2391 (2013). https://doi.org/10.1038/leu.2013.141
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2013.141
This article is cited by
-
Clinicopathological features and prognostic value of SOX11 in childhood acute lymphoblastic leukemia
Scientific Reports (2020)
-
Circular RNA CEP128 acts as a sponge of miR-145-5p in promoting the bladder cancer progression via regulating SOX11
Molecular Medicine (2018)
-
Role of Bruton’s tyrosine kinase in B cells and malignancies
Molecular Cancer (2018)
-
Current Status of Bruton’s Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies
Drugs & Aging (2017)
-
Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma
Current Oncology Reports (2017)